Management of the climacteric

References

• Speroff L, Glass RH, Kase NG. Menopause and the perimenopausal transition. In: Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 6th ed. Baltimore: Lippincott Williams & Wilkins, 1999: 643–724
   Google Scholar
• Torgerson DJ, Avenell A, Russell IT, et al. Factors associated with onset of menopause in women aged 45–49. Maturitas 1994; 19(2): 83–92
   Google Scholar
• Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: a Nordic multicenter study. Am J Obstet Gynecol 1995; 172(5): 1488–94
   PubMed Web of Science ®Google Scholar
• Albrecht BH, Schiff I, Tushinsky D, et al. Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes. Am J Obstet Gynecol 1981; 139(6): 631–5
   Google Scholar
• Schiff I, Tulchinsky D, Cramer D, et al. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA 1980; 244(13): 1443–5
   PubMed Web of Science ®Google Scholar
• Bullock JL, Massey FM, Gambrell RD Jr. Use of medroxyprogesterone acetate to prevent menopausal symptoms. Obstet Gynecol 1975; 46(2):165–8
   Google Scholar
• Morrison JC, Martin DC, Blair RA, et al. The use of medroxyprogesterone acetate for relief of climacteric symptoms. Am J Obstet Gynecol 1980; 138(1): 99–104
   Google Scholar
• Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994; 331(6): 347–52
   PubMed Web of Science ®Google Scholar
• Nesheim BI, Saetre T. Reduction of menopausal hot flushes by methyldopa: a double blind crossover trial. Eur J Clin Pharmacol 1981; 20(6): 413–6
   PubMed Web of Science ®Google Scholar
• Andersen O, Engebretsen T, Solberg VM, et al. alpha-Methyldopa for climacteric hot flushes: a double-blind, randomized, cross-over study. Acta Obstet Gynecol Scand 1986; 65(5): 405–9
   Web of Science ®Google Scholar
• Speroff L, Glass RH, Kase NG. Postmenopausal hormone therapy. In: Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 6th ed. Baltimore: Lippincott Williams & Wilkins, 1999: 725–79
   Google Scholar
• Clayden JR, Bell JW, Pollard P. Menopausal flushing: double-blind trial of a non-hormonal medication. Br Med J 1974; 1(905): 409–12
   Google Scholar
• Laufer LR, Erlik Y, Meldrum DR, et al. Effect of Clonidine on hot flashes in postmenopausal women. Obstet Gynecol 1982; 60(5): 583–6
   Google Scholar
• Edington RF, Chagnon JP, Steinberg WM. Clonidine (Dixarit) for menopausal flushing. Can Med Assoc J 1980; 123(1): 23–6
   PubMed Web of Science ®Google Scholar
• Bolli P, Simpson FO. Clonidine in menopausal flushing: a double-blind trial. N Z Med J 1975; 82(548): 196–7
   Google Scholar
• Ylikorkala O. Clonidine in the treatment of menopausal symptoms. Ann Chir Gynaecol Fenn 1975; 64(4): 242–5
   Google Scholar
• Nappi C, Petraglia F, de Chiara BM, et al. The effect of various drugs with neuroendocrine activity and transdermal estradiol on plasma gonadotropin concentrations after ovariectomy in reproductive-aged women. Acta Obstet Gynecol Scand 1991; 70(6): 435–9
   Web of Science ®Google Scholar
• Wren BG, Brown LB. A double-blind trial with Clonidine and a placebo to treat hot flushes. Med J Aust 1986; 144(7): 369–70
   Google Scholar
• Lindsay R, Hart DM. Failure of response of menopausal vasomotor symptoms to Clonidine. Maturitas 1978; 1(1): 21–5
   Google Scholar
• Sonnendecker EW, Polakow ES. A comparison of oestrogen-progestogen with Clonidine in the climacteric syndrome. SAfr Med J 1980; 58(19): 753–6
   Google Scholar
• Salmi T, Punnonen R. Clonidine in the treatment of menopausal symptoms. Int J Gynaecol Obstet 1979; 16(5): 422–6
   Google Scholar
• Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of Clonidine. Am J Obstet Gynecol 1987; 156(3):561–5
   Google Scholar
• Goldberg RM, Loprinzi CL, O'Fallon JR, et al. Transdermal Clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1994; 12(1): 155–8
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Goldberg RM, O'Fallon JR, et al. Transdermal Clonidine for ameliorating post-orchiectomy hot flashes. J Urol 1994; 151(3): 634–6
   PubMed Web of Science ®Google Scholar
• Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998; 91(1):6–11
   PubMed Web of Science ®Google Scholar
• Murkies AL, Lombard C, Strauss BJ, et al. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 1995; 21(3): 189–95
   PubMed Web of Science ®Google Scholar
• Washburn S, Burke GL, Morgan T, et al. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6(1): 7–13
   Google Scholar
• Lieberman S. A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Womens Health 1988; 7(5): 525–9
   Google Scholar
• Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998; 16(2): 495–500
   PubMed Web of Science ®Google Scholar
• Emmert DH, Kirchner JT. The role of vitamin E in the prevention of heart disease. Arch Fam Med 1999; 8(6): 537–42
   Google Scholar
• Hirata JD, Swiersz LM, Zell B, et al. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fértil Steril 1997; 68(6): 981–6
   PubMed Web of Science ®Google Scholar
• Hendrix SL. Nonestrogen management of menopausal symptoms. Endocrin Metab Clin North Am 1997; 26(2): 379–90
   Google Scholar
• Lebherz TB, French L. Nonhormonal treatment of the menopausal syndrome: a double-blind evaluation of an autonomic system stabilizer. Obstet Gynecol 1969; 33(6): 795–9
   Google Scholar
• Bergmans MG, Merkus JM, Corbey RS, et al. Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study. Maturitas 1987; 9(3): 227–34
   Google Scholar
• Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329(11): 753–6
   PubMed Web of Science ®Google Scholar
• Schmidbauer CP. [Vaginal estriol administration in treatment of postmenopausal urinary incontinence.] Urologe A 1992; 31(6): 384–9 (Ger)
   Google Scholar
• Fantl JA, Bump RC, Robinson D, et al. Efficacy of estrogen supplementation in the treatment of urinary incontinence. Obstet Gynecol 1996; 88(5): 745–9
   Google Scholar
• Rigg LA, Hermann H, Yen SS. Absorption of estrogens from vaginal creams. N Engl J Med 1978; 298(4): 195–7
   Google Scholar
• Henriksson L, Stjernquist M, Boquist L, et al. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996; 174(1 Pt 1): 85–92
   Google Scholar
• Creidi P, Faivre B, Agache P, et al. Effect of a conjugated oestrogen (Premarin) cream on ageing facial skin: a comparative study with a placebo cream. Maturitas 1994; 19(3): 211–23
   PubMed Web of Science ®Google Scholar
• Dunn LB, Damesyn M, Moore AA, et al. Does estrogen prevent skin aging? Results from the First National Health and Nutrition Examination Survey. Arch Dermatol 1997; 133(3): 339–42
   Google Scholar
• Reubinoff BE, Wurtman J, Rojansky N, et al. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril 1995; 64(5): 963–8
   PubMed Web of Science ®Google Scholar
• Wing RR, Matthews KA, Kuller LH, et al. Weight gain at the time of menopause. Arch Intern Med 1991; 151(1): 97–102
   Web of Science ®Google Scholar
• Basson R. Androgen replacement for women. Can Fam Physician 1999; 45(Sep): 2100–7
   Google Scholar
• Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy: sexual behavior and neuroendocrine responses. J Reprod Med 1998: 43(10): 847–56
   PubMed Web of Science ®Google Scholar
• Polo-Kantola P, Erkkola R, Helenius H, et al. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 1998; 178(5): 1002–9
   PubMed Web of Science ®Google Scholar
• Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168(3 Pt l): 824–30
   Google Scholar
• Limouzin-Lamothe MA, Mairon N, Joyce CR, et al. Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol 1994; 170(2): 618–24
   Google Scholar
• Ditkoff EC, Crary WG, Cristo M, et al. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991; 78(6): 991–5
   PubMed Web of Science ®Google Scholar